Briese T, Hakenbeck R
Eur J Biochem. 1985 Jan 15;146(2):417-27. doi: 10.1111/j.1432-1033.1985.tb08668.x.
The choline-containing lipoteichoic acid (LTA, Forssman Antigen) of Streptococcus pneumoniae suppresses the activity of the pneumococcal autolysin, an N-acetyl-muramoyl-L-alanine-amidase (amidase) in aqueous solution [Höltje and Tomasz (1975) Proc. Natl Acad. Sci. USA 72, 1690-1694]. The interaction between LTA and enzyme was used to establish a purification by affinity chromatography on LTA-Sepharose. The amidase could be eluted from the column with choline only. This implies that binding of the enzyme to LTA is mediated via the choline residues of the LTA. Upon binding to the LTA-Sepharose, the amidase converted from the applied E-form (an inactive form of the amidase) to the active C-form, a process which up to now was known to be mediated only by the pneumococcal choline-containing wall teichoic acid. Similar interactions between LTA and amidase seemed to occur in membrane fractions derived from choline-grown cells: the membrane-associated enzyme was present in the C-form and could be detached completely with choline, suggesting that the amidase is bound to the membrane attached LTA rather than being a membrane protein itself. This was supported by the absence of amidase activity in membrane fractions derived from ethanolamine-grown pneumococci, in which choline containing LTA is absent. The LTA-Sepharose-associated amidase was not inhibited, but retained its activity. The enzyme was also not inhibited by lipase-digested LTA. Both are conditions where the LTA is not present in micelles, unlike in aqueous solution. Therefore, mere binding to the LTA is probably not responsible for the inhibitory effect, but inhibition is a manifestation of an inaccessibility of the substrate for the amidase when bound to micellar LTA. When the interactions between choline and amidase were investigated, it was found that high choline concentrations (2%) inhibited the enzyme completely. Even in vivo, 2% choline in the culture medium led to phenotypically amidase-deficient pneumococci. Furthermore, in vitro, low choline concentrations (0.1%) suppressed the wall-mediated conversion. On the other hand, with high choline concentrations (2%) conversion took place in the absence of cell walls. Depending on how the amidase has been converted, the apparent Mr of the resulting C-amidase was different: the cell-wall-converted enzyme was of high Mr, whereas the choline-converted and the LTA-Sepharose-eluted enzyme showed an apparent low molecular mass known for the E-form, when analyzed on sucrose gradients.(ABSTRACT TRUNCATED AT 400 WORDS)
肺炎链球菌含胆碱的脂磷壁酸(LTA,福斯曼抗原)可抑制肺炎球菌自溶素的活性,该自溶素是一种存在于水溶液中的N - 乙酰 - 胞壁酰 - L - 丙氨酸酰胺酶(酰胺酶)[Höltje和Tomasz(1975年)《美国国家科学院院刊》72, 1690 - 1694]。利用LTA与酶之间的相互作用,通过在LTA - 琼脂糖上进行亲和层析来实现纯化。酰胺酶只能用胆碱从柱上洗脱下来。这意味着酶与LTA的结合是通过LTA的胆碱残基介导的。与LTA - 琼脂糖结合后,酰胺酶从施加的E型(酰胺酶的无活性形式)转变为活性C型,到目前为止已知该过程仅由肺炎球菌含胆碱的壁磷壁酸介导。LTA与酰胺酶之间类似的相互作用似乎也发生在源自胆碱培养细胞的膜组分中:膜相关酶以C型存在,并且可以用胆碱完全分离,这表明酰胺酶与膜附着的LTA结合,而不是其本身就是一种膜蛋白。这一点得到了乙醇胺培养的肺炎球菌膜组分中不存在酰胺酶活性的支持,在这种膜组分中不含含胆碱的LTA。与LTA - 琼脂糖结合的酰胺酶未被抑制,而是保留了其活性。该酶也未被脂肪酶消化的LTA抑制。这两种情况都是LTA不以胶束形式存在,与在水溶液中不同。因此,仅仅与LTA结合可能不是抑制作用的原因,而是当与胶束状LTA结合时,底物对酰胺酶不可接近的一种表现。当研究胆碱与酰胺酶之间的相互作用时,发现高浓度胆碱(2%)可完全抑制该酶。即使在体内,培养基中2%的胆碱也会导致表型上酰胺酶缺陷的肺炎球菌。此外,在体外,低浓度胆碱(0.1%)会抑制细胞壁介导的转变。另一方面,在高浓度胆碱(2%)存在时,在没有细胞壁的情况下也会发生转变。根据酰胺酶的转变方式不同,所得C型酰胺酶的表观分子量也不同:经细胞壁转变的酶分子量高,而经胆碱转变和LTA - 琼脂糖洗脱的酶在蔗糖梯度分析时显示出E型已知的低分子量。(摘要截短至400字)